Michael J. LaBarre
2008
In 2008, Michael J. LaBarre earned a total compensation of $474.3K as Vice President, Product Development at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $31,904 |
|---|---|
| Option Awards | $314,985 |
| Salary | $127,292 |
| Other | $133 |
| Total | $474,314 |
LaBarre received $315K in option awards, accounting for 66% of the total pay in 2008.
LaBarre also received $31.9K in non-equity incentive plan, $127.3K in salary and $133 in other compensation.
Rankings
In 2008, Michael J. LaBarre's compensation ranked 6,681st out of 9,135 executives tracked by ExecPay. In other words, LaBarre earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,681 out of 9,135 | 27th |
Division Manufacturing | 2,485 out of 3,436 | 28th |
Major group Chemicals And Allied Products | 557 out of 815 | 32nd |
Industry group Drugs | 387 out of 597 | 35th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 118 | 49th |
Source: SEC filing on March 24, 2011.
LaBarre's colleagues
We found six more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2008.
2008
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2008
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2008
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2008
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2008
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2008
David Ramsay
Halozyme Therapeutics